Randomized controlled trial to determine the efficacy and safety of daikenchuto for abdominal pain and bloating sensation of IBS - Randomized controlled trial of the effect of daikenchuto on IBS symptom

TJ-100 IBS study group0 个研究点目标入组 60 人开始时间: 2009年3月25日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patients who have bowel move disturbance by organic lesion such as IBD(UC and crohn disease etc.) and cancer. 2) Patients suspected of obstruction in stomach and intestines, and with a history of total gastric resection or bowel resection but not apendicitis 3) Patients with hypercalcemia, calculus in the kidney and dysfunction of kidneys. 4) Patients who are taking cardiac glycoside and tetracyclines antibiotics. 5) Patients who took antibiotics at least 2 month prior to observation period 6) Patients with serious complications (liver, kidney, heart, lung, circulatory, or metabolic disorder) 7) Patients with a history of drug allergy 8) Patients who are nursing, pregnant or considering conception 9) Patients who are taking Kampo medicine. 10) Others, including patients who are unfit for the study as determined by the research director or others

发起方

TJ-100 IBS study group